Pregnancy outcome after treatment with etoposide (VP-16) for low-risk gestational trophoblastic tumor

International Journal of Gynecological Cancer

Volumn 9, Issue 2, 1999, Pages 166-169

  Matsui, H ^a   Iitsuka, Y ^a   Seki, K ^a   Sekiya, S ^a  

^a CHIBA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Etoposide; Gestational trophoblastic tumor; Pregnancy outcome

Indexed keywords

ETOPOSIDE;

ADULT; ARTICLE; FEMALE; FEMALE FERTILITY; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; OUTCOMES RESEARCH; PREGNANCY COMPLICATION; PRIORITY JOURNAL; REMISSION; RISK ASSESSMENT; SPONTANEOUS ABORTION; TROPHOBLASTIC DISEASE;

EID: 0032895888     PISSN: 1048891X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1525-1438.1999.99018.x     Document Type: Article

References (14)

1. Hammond CB, Hertz R, Ross GT. Primary chemotherapy for nonmetastatic gestational trophoblastic neoplasms. Am J Obstet Gynecol 1967; 98: 71-8.
2. Berkowitz RS, Goldstein DP, Bernstein MR. Ten year's experience with methotrexate and folic acid as primary therapy for gestational trophoblastic disease. Gynecol Oncol 1986; 23: 111-8.
3. Schlaerth JB, Morrow CP, Nalick RH, Gaddis Jr, G. Single-dose actinomycin D in the treatment of postmolar trophoblastic disease. Gynecol Oncol 1984; 19: 53-6.
4. Wong LC, Choo YC, Ma HK. Primary oral etoposide therapy in gestational trophoblastic disease: An update. Cancer 1986; 58: 14-7.
5. Hitchins RN, Holden L, Newlands ES, Begent RHJ, Rustin GJS, Bagshawe KD. Single agent etoposide in gestational trophoblastic tumours: Experience at Charing Cross Hospital 1978-1987. Eur J Cancer Clin Oncol 1988; 24: 1041-6.
6. Matsui H, Iitsuka Y, Seki K, Sekiya S. Etoposide (VP-16) as first-line single agent chemotherapeutic drug in low-risk gestational trophoblastic disease. Int J Gynecol Cancer 1997; 7: 400-4.
7. Matsui H, Seki K, Sekiya S, Takamizawa H. Reproductive status of patients with gestational trophoblastic disease treated with etoposide. J Reprod Med 1997; 42: 104-10.
8. Bagshawe KD, Dent J, Newlands ES, Begent RHJ, Rustin GJS. The role of low-dose methotrexate and folic acid in gestational trophoblastic tumours (GTT). Br J Obstet Gynaecol 1989; 96: 795-802.
9. Matsui H, Iitsuka Y, Seki K, Sekiya S. Comparison of chemotherapies with methotrexate, VP-16 and actinomycin-D in low-risk gestational trophoblastic disease-remission rates and drug toxicities. Gynecol Obstet Invest 1998; 46: 5-8.
10. Rustin GJS, Newlands ES, Lutz J-M, Holden L, Bagshawe KD, Hiscox JG, Foskett M, Fuller S, Short D. Combination but not single-agent methotrexate chemotherapy for gestational trophoblastic tumors increases the incidence of second tumors. J Clin Oncol 1996; 14: 2769-73.
11. Choo YC, Chan SYW, Wong LC, Ma HK. Ovarian dysfunction in patients with gestational trophoblastic neoplasia treated with short intensive courses of etoposide (VP-16-213). Cancer 1985; 55: 2348-52.
12. Ngan HYS, Wong LC, Ma HK. Reproductive performance of patients with gestational trophoblastic disease in Hong Kong. Acta Obstet Gynecol Scand 1988; 67: 11-4.
13. Rustin GJS, Booth M, Dent J, Salt S, Rustin F, Bagshawe KD. Pregnancy after cytotoxic chemotherapy for gestational trophoblastic tumours. Br Med J 1984; 288: 103-6.
14. Berkowitz RS, Im SS, Bernstein MR, Goldstein DP. Gestational trophoblastic disease: Subsequent pregnancy outcome, including repeat molar pregnancy. J Reprod Med 1988; 43: 81-6.